Gradient reduction after percutaneous septal ablation modifies the risk profile in hypertrophic obstructive cardiomyopathy

被引：0
|
作者：
Faber, L. [1 ]
Burghardt, A. [1 ]
Seggewiss, H. [2 ]
Van Buuren, F. [1 ]
Horstkotte, D. [1 ]
机构：
[1] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Dept Cardiol, Bad Oeynhausen, Germany
[2] Leopoldina Hosp, Med Clin 1, Schweinfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2638
引用
收藏
页码：452 / 453
页数：2
相关论文
共 50 条
  • [31] APPLICATION OF PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION ON HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Wang Yu
    Liu Hongming
    Zhang Hongjie
    Guo Tao
    HEART, 2012, 98 : E250 - E250
  • [32] Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    Zhang, WW
    Li, ZQ
    Zhang, M
    Yuan, L
    Guan, RM
    Hou, AJ
    Jin, YZ
    Deng, ZX
    CHINESE MEDICAL JOURNAL, 2002, 115 (09) : 1283 - 1286
  • [33] Reduction in mitral regurgitation after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Crawford, FA
    Nielsen, C
    Fernandes, V
    Frankis, M
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 146A - 146A
  • [34] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Amelie Burghardt
    Frank van Buuren
    Zisis Dimitriadis
    Tim Grübbel
    Hubert Seggewiss
    Smita Scholtz
    Dieter Horstkotte
    Lothar Faber
    Clinical Research in Cardiology, 2018, 107 : 479 - 486
  • [35] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Burghardt, Amelie
    van Buuren, Frank
    Dimitriadis, Zisis
    Gruebbel, Tim
    Seggewiss, Hubert
    Scholtz, Smita
    Horstkotte, Dieter
    Faber, Lothar
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (06) : 479 - 486
  • [36] Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Sorajja, Paul
    Ommen, Steve R.
    Holmes, David R., Jr.
    Dearani, Joseph A.
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Lennon, Ryan J.
    Nishimura, Rick A.
    CIRCULATION, 2012, 126 (20) : 2374 - 2380
  • [37] Quantification of myocardial injury after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    van Dockum, WG
    ten Cate, FJ
    ten Berg, JM
    Hofman, MBM
    Beek, AM
    van Rossum, AC
    EUROPEAN HEART JOURNAL, 2002, 23 : 733 - 733
  • [38] Quantification of myocardial injury after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    van Dockum, WG
    ten Cate, FJ
    ten Berg, JM
    Beek, AM
    van Rossum, AC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 132A - 132A
  • [39] Incidence and chronology of atrioventricular block and outcomes after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Barcelo, Maria Calvo
    Adelino, Raquel
    Belahnech, Yassin
    Jordan-Marchite, Pablo
    Rivas-Gandara, Nuria
    Pascual, Jaume Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2025, 78 (04): : 371 - 374
  • [40] Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
    Qin, JX
    Shiota, T
    Lever, HM
    Kapadia, SR
    Sitges, M
    Rubin, DN
    Bauer, F
    Greenberg, NL
    Agler, DA
    Drinko, JK
    Martin, M
    Tuzcu, EM
    Smedira, NG
    Lytle, B
    Thomas, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 1994 - 2000
12345